SPDR S&P Biotech ETF
180 hedge funds and large institutions have $2.76B invested in SPDR S&P Biotech ETF in 2015 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 11 closing their positions.
Holders
180
Holders Change
+34
Holders Change %
+23.29%
% of All Funds
4.8%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.27%
New
50
Increased
48
Reduced
47
Closed
11
Calls
$245M
Puts
$701M
Net Calls
-$456M
Net Calls Change
-$385M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$382M |
| 2 |
2
Citigroup
New York
|
$217M |
| 3 |
3
BNP Paribas Financial Markets
Paris,
France
|
$113M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$205M |
| 5 |
5
Goldman Sachs
New York
|
$814M |
